Orpharma

Orpharma is an Australian specialty pharmaceutical company focused on orphan, paediatric, and niche therapeutics, with a particular emphasis on rare metabolic disorders. The company appears to operate primarily as a commercial-stage supplier and commercialization partner rather than a discovery-stage biotech, offering rare-disease medicines, medical nutrition products, and low-protein foods. Publicly referenced products include Pheburane for hyperammonaemia in urea cycle disorders and TYR Easy Tablets for dietary management of tyrosinaemia. Orpharma is described by third-party sources as collaborating with global biotechnology and pharmaceutical companies to bring underserved therapies to Australian patients. Its business focus is concentrated in rare disease access, metabolic disease support products, and specialty therapeutics distribution.